CompletedNot Applicable

Impact of Vaccine Education Program on Vaccine Advocacy and Vaccine Literacy

Turkey (Türkiye)74 participantsStarted 2023-07-03

Plain-language summary

This research will be carried out as a randomized controlled study with a waitlist in parallel design to evaluate the effect of the vaccine education and vaccine advocacy program prepared according to The Integrated Change Model on the level of vaccination literacy and the transformation into vaccine advocates. Research hypothesis "H0a: Vaccine education program prepared according to The Integrated Change Model does not affect vaccine literacy, H0b: The vaccine training program prepared according to the integrated change model does not affect the concepts (information sources, intention, attitude, behavior, obstacles) in the integrated change model determined for vaccine advocacy. At the end of the training, it is thought that the mothers in the experimental group will be different from the control group regarding vaccine literacy and the vaccine advocacy concepts (information sources, intention, attitude, behavior) in the model.

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. To be residing in Artvin city center
. To have applied to the Family Health Center No. 1 or 2 in the city center for any reason.
. Having at least a high school graduate education level
. Having a child in the age range that covers the national vaccination calendar (0-13 years old)
. Turkish - speaking
. Being literate
. Being 18 years or older
. Volunteering to participate in research

Exclusion criteria

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Vaccine literacy

Timeframe: 01.08.2023-31.08.2023 (within 1 month on average)

Vaccine advocacy intention

Timeframe: 01.08.2023-31.08.2023 (within 1 month on average)

vaccine attitudes

Timeframe: 01.08.2023-31.08.2023 (within 1 month on average)

Trial details

NCT IDNCT05929053

SponsorArtvin Coruh University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Unrecognized Condition trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. To be residing in Artvin city center
. To have applied to the Family Health Center No. 1 or 2 in the city center for any reason.
. Having at least a high school graduate education level
. Having a child in the age range that covers the national vaccination calendar (0-13 years old)
. Turkish - speaking
. Being literate
. Being 18 years or older
. Volunteering to participate in research